INFECTION WITH <i>MYCOPLASMA PNEUMONIAE</i> IN CIVILIANS IN THE NETHERLANDS

Hers, J.; Masurel, N.

doi:10.1111/j.1749-6632.1967.tb27689.x

Cited by 59 publications

(14 citation statements)

References 42 publications

(8 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thirteen more cases were identified through cross-references; four of these cases were diagnosed as TTP and excluded from this review. Three cases were mentioned in a report of 83 patients with M. pneumonia infection, but lack details on the clinical presentation, platelet counts and outcome of the clinical course [2]. The details of the remaining 7 cases and our case of thrombocytopenia associated with M. pneumonia infection with no features of TTP or DIC are summarized in Table 1.…”

Section: Literature Reviewmentioning

confidence: 99%

Mycoplasma pneumonia Infection: A Possible Trigger for Immune Thrombocytopenia

Aviner

Miskin

London

et al. 2011

Indian J Hematol Blood Transfus

View full text Add to dashboard Cite

Mycoplasma pneumonia (M. pneumonia) is usually not considered among the several pathogens that induce immune thrombocytopenia (ITP). We report a child with a clinical diagnosis of severe ITP that was associated with M. pneumonia pneumonia, and review the few cases described in the English literature. We suggest that thrombocytopenia associated with M. pneumonia infection may constitute a subset of ITP, although unlike ITP it occurs concomitantly with the infection and tends to be more severe than ''classic'' ITP. We recommend that prompt specific antibiotic and immune modulating treatment should be initiated in appropriate clinical settings.

show abstract

Section: Literature Reviewmentioning

confidence: 99%

Mycoplasma pneumonia Infection: A Possible Trigger for Immune Thrombocytopenia

Aviner

Miskin

London

et al. 2011

Indian J Hematol Blood Transfus

View full text Add to dashboard Cite

show abstract

“…pneumoniae epidemics have been described in families, schools, military establishments and universities, reflecting the droplet-borne transmission of the disease [10]. However, important epidemiological fluctuations of M. pneumoniae infection with peak incidences every four to seven years have also been described in larger commu- [4][5][6][7][8][9]. Outbreaks and epidemiological surveys of M. pneumoniae infection published before 1970 have been reviewed in depth by Denny et al [11].…”

Section: Discussionmentioning

confidence: 98%

“…Important epidemiological fluctuations of M. pneumoniae infection, with peak incidences every four to seven years have been described in long-term studies in several countries [4][5][6][7][8][9]. However, no data on the epidemiology of M. pneumoniae infection are available for central Europe.…”

Section: An Unrecognized Epidemic Of Mycoplasma Pneumoniae Infection mentioning

confidence: 99%

An unrecognized epidemic of Mycoplasma pneumoniae infection in Vienna

Daxboeck

Bauer

Assadian

et al. 2006

Wien Klin Wochenschr

View full text Add to dashboard Cite

Mycoplasma pneumoniae infection shows epidemiological peaks with a 2- to 10-fold increased incidence every four to seven years. The regional epidemiology of M. pneumoniae infection is important with regard to empirical antibiotic treatment of community-acquired respiratory tract infections, which are the most common cause for visiting a physician. To date, no data on the epidemiology of M. pneumoniae in central Europe have been published. In the present study, the results of M. pneumoniae serology performed at the Clinical Division of Virology at Vienna General Hospital (a 2,140-bed university teaching hospital with an average of 94,000 admissions/year and 430,000 outpatient visits/year) in the 10-year period from January 1995 to December 2004 were analyzed retrospectively. Antibody titers > or = 1:64 in complement fixation tests were considered indicative of acute or recent mycoplasma infection. The annual total number of serum specimens tested for anti-M. pneumoniae antibodies remained stable throughout the study period (median: 2859 samples/year, range: 2257-3338). The annual median number of patients with high M. pneumoniae titers was 13. A major epidemiological peak (43 patients) was observed in 2000, the epidemic starting in late 1999 and ending in 2001. A surveillance or reporting system for M. pneumoniae infections (i.e. positive serological results for M. pneumoniae) would be useful for physicians caring for patients with community-acquired respiratory tract infections.

show abstract

“…A standard history was taken and all patients submitted to the following tests before and one day after completion of therapy (day 8): Gram stain of urethral discharge and culture of urethral samples for Ureaplasma urealyticurn (6)(7)(8)(9), Chlamydia trachomatis (6, i0) and Neisseria gonorrhoeae (6), All patients were men attending the outpatient clinic for sexually transmitted diseases at the University Hospital Rotterdam-Dijkzigt.…”

Section: Clinical Efficacy Of Ciprofloxacin Versus Doxyeycline In Thementioning

confidence: 99%

Clinical efficacy of ciprofloxacin versus doxycycline in the treatment of non-gonococcal Urethritis in males

Willigen

Polak-Vogelzang

Habbema

et al. 1988

Eur. J. Clin. Microbiol. Infect. Dis.

View full text Add to dashboard Cite

In a randomised study the clinical efficacy of ciprofloxacin was compared with that of doxycycline administered in two different dosage schemes to male patients suffering from non-gonococcal urethritis. Fourteen days after completion of therapy (day 21) pyuria was absent in 30 of 100 patients in the ciprofloxacin group; Chlamydia trachomatis was isolated from five and Ureaplasma urealyticum from eight patients. In the 100 mg doxycycline group (n = 60) pyuria was absent in 36 patients (60%) and Ureaplasma urealyticum was isolated from six patients on day 21. In the 200 mg doxycycline group (n = 45) pyuria was absent in 18 patients (40%) and Ureaplasma urealyticum was isolated from two patients on day 21. Side-effects were mild and transient in all groups. It is concluded that ciprofloxacin given in a dosage of 1 g for seven days is not effective in the treatment of non-gonococcal urethritis.

show abstract

INFECTION WITH MYCOPLASMA PNEUMONIAE IN CIVILIANS IN THE NETHERLANDS

Cited by 59 publications

References 42 publications

Mycoplasma pneumonia Infection: A Possible Trigger for Immune Thrombocytopenia

Mycoplasma pneumonia Infection: A Possible Trigger for Immune Thrombocytopenia

An unrecognized epidemic of Mycoplasma pneumoniae infection in Vienna

Clinical efficacy of ciprofloxacin versus doxycycline in the treatment of non-gonococcal Urethritis in males

Contact Info

Product

Resources

About